Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 4
2011 3
2012 1
2013 1
2014 2
2016 3
2018 1
2019 2
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study - 6 month results.
Khanani AM, Aziz AA, Khan H, Gupta A, Mojumder O, Saulebayeva A, Abbey AM, Almeida DRP, Avery RL, Banda HK, Barakat MR, Bhandari R, Chang EY, Haug SJ, London NJS, Mein L, Sheth VS, Wolfe JD, Singer MA, Danzig CJ. Khanani AM, et al. Among authors: london njs. Eye (Lond). 2023 Dec;37(17):3574-3581. doi: 10.1038/s41433-023-02553-5. Epub 2023 May 12. Eye (Lond). 2023. PMID: 37173428 Free PMC article.
Drugs, Inflammation, and the Eye.
Cunningham ET Jr, London NJ, Moorthy R, Garg SJ, Zierhut M. Cunningham ET Jr, et al. Ocul Immunol Inflamm. 2016;24(2):125-7. doi: 10.3109/09273948.2016.1160683. Ocul Immunol Inflamm. 2016. PMID: 27074544 No abstract available.
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
Drug-induced uveitis.
Moorthy RS, London NJ, Garg SJ, Cunningham ET Jr. Moorthy RS, et al. Curr Opin Ophthalmol. 2013 Nov;24(6):589-97. doi: 10.1097/01.icu.0000434534.32063.5c. Curr Opin Ophthalmol. 2013. PMID: 24100371 Free article. Review.
HIV/AIDS in the developing world.
London NJ, Shukla D, Heiden D, Rathinam SR, Arevalo JF, Cunningham ET Jr. London NJ, et al. Int Ophthalmol Clin. 2010 Spring;50(2):201-18. doi: 10.1097/IIO.0b013e3181d26fcf. Int Ophthalmol Clin. 2010. PMID: 20375872 Review. No abstract available.
Leukemia presenting as serous retinal detachment.
Smith AG, London NJ, Pao K, Lipkowitz J, Kurup SK, Garg SJ. Smith AG, et al. Retin Cases Brief Rep. 2014 Fall;8(4):279-82. doi: 10.1097/ICB.0000000000000074. Retin Cases Brief Rep. 2014. PMID: 25372528 Review.
The epidemiology of uveitis in developing countries.
London NJ, Rathinam SR, Cunningham ET Jr. London NJ, et al. Int Ophthalmol Clin. 2010 Spring;50(2):1-17. doi: 10.1097/IIO.0b013e3181d2cc6b. Int Ophthalmol Clin. 2010. PMID: 20375859 Review. No abstract available.
Diagnostic and Therapeutic Challenges.
Introini U, Casalino G, Parodi MB, Bandello F, London NJ. Introini U, et al. Retina. 2016 Feb;36(2):422-7. doi: 10.1097/IAE.0000000000000591. Retina. 2016. PMID: 26066702 No abstract available.
21 results